Bortezomib: an effective therapy even in cardiac AL patients previously deemed unsalvageable

Back

ESC Premium Access

Bortezomib: an effective therapy even in cardiac AL patients previously deemed unsalvageable

Session: Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension

Topic: Drug therapy

Speaker: Doctor A. Singh (Boston, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Avinainder Singh

Brigham and Women's Hospital, Boston (United States of America)

0 follower

5 more presentations in this session

Prevalence of cardiomyopathy in patients with familial amyloid neuropathy: a report from the NEURO-TTR Trial

Speaker: Assistant Professor S. Heitner (South San Francisco, US)

Access

Abstract

Slides

Higher prevalence of hypertension in the migrant population in Italy: data derived from the 2012 and 2013 world kidney day

Speaker: Associate Professor S. Perlini (Pavia, IT)

Access

Abstract

Slides

Impact of patients' wealth categories on antihypertensive drugs intake in 12 sub-saharan countries: EIGHT Study

Speaker: Doctor M. Antignac (Paris, FR)

Access

Abstract

Slides

Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in hypertensive patients with diabetes treated with telmisartan plus diuretic

Speaker: Professor Y. Dohi (Nagoya, JP)

Access

Abstract

Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan

Speaker: Associate Professor S. Chua (Kaohsiung, TW)

Access

Abstract

Slides

Access the full session

Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension

Speakers: Doctor A. Singh, Assistant Professor S. Heitner, Associate Professor S. Perlini, Doctor M. Antignac, Professor Y. Dohi...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources